Show simple item record

dc.contributor.authorCellamare, M
dc.contributor.authorVentz, S
dc.contributor.authorBaudin, E
dc.contributor.authorMitnick, CD
dc.contributor.authorTrippa, L
dc.date.accessioned2017-02-22T17:54:55Z
dc.date.available2017-02-22T17:54:55Z
dc.date.issued2016-08-23
dc.date.submitted2016-08-30
dc.identifier.citationA Bayesian response-adaptive trial in tuberculosis: The endTB trial. 2016: Clin Trialsen
dc.identifier.issn1740-7753
dc.identifier.pmid27559021
dc.identifier.doi10.1177/1740774516665090
dc.identifier.urihttp://hdl.handle.net/10144/618804
dc.descriptionWe regret that this article is behind a paywall.en
dc.description.abstractTo evaluate the use of Bayesian adaptive randomization for clinical trials of new treatments for multidrug-resistant tuberculosis.
dc.languageENG
dc.language.isoenen
dc.publisherSAGE Publicationsen
dc.titleA Bayesian Response-Adaptive Trial in Tuberculosis: The endTB Trialen
dc.identifier.journalClinical Trialsen
dc.internal.reviewer-noteClinical Trials - Sageen
html.description.abstractTo evaluate the use of Bayesian adaptive randomization for clinical trials of new treatments for multidrug-resistant tuberculosis.


This item appears in the following Collection(s)

Show simple item record